http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0112871-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2458
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-224
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-2487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
filingDate 1983-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1987-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1987-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0112871-B1
titleOfInvention Derivatives of n,n-bis(2-chloroethyl)-phosphoric acid amide
abstract Derivatives of N,N-bis-(2-chloroethyl)-phosphoric acid amide having the general formula (I), wherein the symbols X and Y, being identical or different, represent oxigen or a NR3 group, and wherein the symbols R1 and R2 have a different or identical meaning, the symbol R1 representing CH2(OR4)-CH2-CH2-, CH2(OR4)-CH(CH3)-CH2- or CH2(OR4)-CH(OR5)-CH2-rest, the symbol R1 representing also hydrogen when the symbol X represents a group NR3 and the symbol R2 of the formula designates one of the meanings of the symbol R1 or one of the rests ethyl, propyl, allyl, propenyl, chlorethyl, methyl or benzyl, the preceding symbol R3 representing hydrogen, methyl, ethyl, propyl or allyl and the preceding symbols R4 and R5, having an identical or different meaning, designate and alkyl rest R or an acyl rest -COR, wherein R represents a saturated or unsaturated straight or branched chain alkyl group with 1 to 25 atoms of carbon or an aralkyl group with 1 to 25 atoms of carbon in the alkyl portion, and one of the rests representing as well a hydrogen atom. The invention also relates to methods for the preparation of such compounds. The compounds of the invention have a particularly efficient antitumoral activity comparable to the known activity of cyclophosphamide compounds.
priorityDate 1982-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70444730
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455784172
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID165802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449662972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415972042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415912166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233612466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236043109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236068709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235904017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449350972
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415823637
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9554281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158480319
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88672972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID177358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229755366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574964
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID95691
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860710
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54086130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID459930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96271
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425534311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415798716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24813

Total number of triples: 77.